Hypokalemia in Hospitalized Patients for Heart Failure in the Therapeutic Cardiac Failure Unit

Heart Failure Clinical Trial

— HYPIC  

Official title:

Hypokalemia in Hospitalized Patients for Heart Failure in the Therapeutic Cardiac Failure Unit: Morbidity-mortality Impact

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03405051
• Other study ID #: 2017-03Obs-CHRMT
• Status: Completed
• Start date: November 15, 2017
• Est. completion date: February 1, 2019

Study information

• Verified date: December 2017
• Source: Centre Hospitalier Régional Metz-Thionville
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Hypokalemia is very common in heart failure patients. Deleterious effects have been report on the cardiovascular system. Most of the clinical data concerning this ionic trouble are based on post-hoc study and some findings seemed disjointed.

Description:

This study tried to describe hypokalemia impact during hospital stay in hospitalized patients with heart failure and particularly on mortality and re-hospitalization.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 250
• Est. completion date: February 1, 2019
• Est. primary completion date: November 15, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Hospitalized patient in the Therapeutic Cardiac Failure Unit in the CHR Metz-Thionville

• Patient with congestive heart failure

Exclusion Criteria:

Related Conditions & MeSH terms

• Heart Failure
• Hypokalemia

Locations

Country	Name	City	State
France	CHR Metz-Thionville	Metz

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Régional Metz-Thionville

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Composite of death and re-hospitalization	The number of death for any reason and re-hospitalization for congestive heart failure	Month 3
Secondary	Death	Percentage of death for any reason	Month 3
Secondary	Re-hospitalization	Percentage of re-hospitalization for congestive heart failure	Month 3
Secondary	Length of stay	Days spent at the hospital	Month 3
Secondary	Incidence of hypokalemia	Percentage of incidence during the stay of hypokalemia	Month 3
Secondary	Prevalence of hypokalemia	Percentage of initial prevalence during the stay of hypokalemia	Month 3